{
    "SPADE_UN_20477": {
        "Sequence Information": {
            "Peptide Name": "Human Cathelicidin / LL-37 (16-32)[F2,12f][I5,9i]",
            "Sequence": "EFKRIVQRIKDFLRNLV",
            "Sequence Length": 17,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "5XRX",
            "UniProt Entry": [
                {
                    "uniprotId": "P49913",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/P49913",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."
                },
                {
                    "uniprotId": "Q1KLX1",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/Q1KLX1",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."
                },
                {
                    "uniprotId": "J3KNB4",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/J3KNB4",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37",
                    "Pubmed ID": "19029324",
                    "Reference": "Antimicrob Agents Chemother. 2009;53:593-602",
                    "Author": "Strömstedt AA, Pasupuleti M, Schmidtchen A, Malmsten M",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/19029324"
                }
            ],
            "Mass": 2174.59,
            "PI": 10.9,
            "Net Charge": 3,
            "Hydrophobicity": -0.28,
            "Frequent Amino Acids": "RFI",
            "Absent Amino Acids": "ACGHMOPSTUWY",
            "Basic Residues": 5,
            "Acidic Residues": 2,
            "Hydrophobic Residues": 8,
            "Polar Residues": 9,
            "Positive Residues": 5,
            "Negative Residues": 2,
            "SPADE ID": "SPADE_UN_20477",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_02277",
                    "Similarity": 1.0,
                    "Sequence": "GDFFRKSKEKIGKEFKRIVQRIKDFLRN"
                },
                {
                    "SPADE_ID": "SPADE_N_02334",
                    "Similarity": 1.0,
                    "Sequence": "LLGDFFRKAREKIGEEFKRIVQRIKDFLRNLVPRTES"
                },
                {
                    "SPADE_ID": "SPADE_N_03100",
                    "Similarity": 1.0,
                    "Sequence": "KSKEKIGKEFKRIVQRIKDFLRNLVPR"
                }
            ],
            "Hemolytic Activity": "",
            "Target Organism": "Pseudomonas aeruginosa ATCC 27853(MIC=>80µM),Pseudomonas aeruginosa 15159(MIC=>80µM),Staphylococcus aureus ATCC 29213(MIC=>80µM),Staphylococcus aureus FDA 486(MIC=>80µM),Staphylococcus aureus 2844(MIC=>80µM)"
        }
    }
}